Cochrane Abstracts
Endovascular revascularisation versus conservative management for intermittent claudication
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Endovascular Revascularisation Versus Conservative Management for Intermittent Claudication." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438695/all/Endovascular_revascularisation_versus_conservative_management_for_intermittent_claudication.
Endovascular revascularisation versus conservative management for intermittent claudication. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438695/all/Endovascular_revascularisation_versus_conservative_management_for_intermittent_claudication. Accessed January 12, 2025.
Endovascular revascularisation versus conservative management for intermittent claudication. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438695/all/Endovascular_revascularisation_versus_conservative_management_for_intermittent_claudication
Endovascular Revascularisation Versus Conservative Management for Intermittent Claudication [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2025 January 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438695/all/Endovascular_revascularisation_versus_conservative_management_for_intermittent_claudication.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Endovascular revascularisation versus conservative management for intermittent claudication
ID - 438695
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438695/all/Endovascular_revascularisation_versus_conservative_management_for_intermittent_claudication
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
